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Abstract
Beijing strains of Mycobacterium tuberculosis (lineage 2) have been associated with
drug-resistance and transmission of tuberculosis worldwide. Most of the Beijing strains
identified in the Colombian Pacific coast have exhibited a multidrug resistant (MDR) phe-
notype. We sought to evaluate the clonality and sublineage of Beijing strains circulating in
Southwestern Colombia. Thirty-seven Beijing strains were identified through spoligotyp-
ing out of 311 clinical isolates collected in 9 years from 2002–2010. Further analysis by
MIRU-VNTR 24 loci was conducted for the Beijing strains. For sublineage classification,
deletions of RD105, RD207, and RD131 and point mutations at fbpB, mutT2, and acs
were evaluated. Drug-resistance associated mutations to first- and second-line anti-TB
drugs were also evaluated. Additionally, two Beijing strains were Illumina-whole genome
sequenced (one MDR and one drug-susceptible). Among the 37 Beijing strains character-
ized, 36 belonged to the SIT190 type from which 28 were MDR, four pre-extensively drug
resistant (XDR) TB, and four XDR-TB. The remaining strain was SIT1 and drug suscepti-
ble. MIRU-VNTR analysis allowed the identification of three Beijing clusters and two
unique strains. Beijing strains were confirmed as “modern” sublineage. The mutations
rpoB S531L and katG S315T were the most common among MDR strains. Moreover, the
two strains evaluated by whole genome sequencing (WGS) shared most of the genetic
features with the sublineage 2.2.1 “modern” Beijing previously characterized from Asian
strains. WGS analysis of the MDR strain revealed the presence of eight SNPs previously
reported in other MDR “Beijing-like” strains from Colombia. The presence of “modern”
Beijing strains in Southwestern Colombia, most of them with MDR phenotype, suggests a
different origin of this M. tuberculosis sublineage compared to other Beijing strains found
in neighboring South American countries. This work may serve as a genetic baseline to
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Introduction
Tuberculosis (TB) is still the leading cause of death worldwide due to a single infectious patho-
gen, largely because of the dissemination of drug resistant Mycobacterium tuberculosis (Mtb)
strains [1] The Beijing genotype, one of the most successful and virulent lineages of Mtb, has
been correlated with active transmission of multidrug resistant (MDR) and extensively drug
resistant (XDR) TB [2–5]. Beijing is the major representative strain of the lineage 2 (East-
Asian lineage), which is defined by the deletion of region of difference (RD) RD105 [6, 7].
Two different sublineages of Beijing, the “ancient” (atypical) and “modern” (typical) strains
have been described. The two variants show differences in geographical distribution, drug
resistance, and virulence patterns. The “ancient” sublineage has been found predominantly in
Russia, Korea, and Japan [8–10], while “modern” sublineage is distributed worldwide and has
been largely associated with drug resistance and hypervirulence [11–13].
Although the prevalence of Beijing strains is not high in South America [14], several coun-
tries of the region have now reported the presence of this genotype among clinical isolates [9,
15–18]. In Peru, the proportion of Beijing strains seems to be increasing in the last decade (9%
to 16%), with a predominance of the “modern” sublineage, although not highly associated
with drug resistance [9, 19]. Similarly, Beijing strains were detected only among pan-drug sus-
ceptible TB cases in Paraguay [17]. On the other hand, Beijing strains from Ecuador have been
found in both drug susceptible and resistant TB cases, although not clustered [18, 20].
In Colombia, there has been evidence of association between Beijing strains and drug
resistance. In 1998, a study conducted in Buenaventura -the main port city on the Colombian
Pacific coast- reported a proportion of 10% (11/111) of Beijing strains, three of which were
MDR [15]. Later, we identified a cluster of 24 Beijing Spoligo-International-Type (SIT) 190
strains among MDR and XDR Mtb isolates in Southwestern Colombia [21, 22]. A high propor-
tion of those Beijing strains were isolated from pulmonary MDR-TB (96%) patients from Bue-
naventura (92%) [21]. According to the SpolDB4 database, the Beijing SIT190 strains observed
in the Colombian Pacific coast have been also observed in the United States, Japan, Cuba,
among other countries [23].
Here, we aimed to perform a comprehensive genetic characterization of Beijing strains cir-
culating in Southwestern Colombia, to define its genetic sublineage, clustering and confirm
its association with MDR. This work may serve as a genetic baseline to study transmission
dynamics and spreading of Mtb “modern” Beijing strains in Colombia, which play an impor-
tant role in the control of MDR-TB.
Materials and methods
Ethics statement
The Institutional Review Board of the International Center for Medical Research and Training
(CIDEIM) approved this study, authorizing a waiver of informed consent from the human
research subjects who provided the samples. Additionally, data was anonymously analyzed,
and confidentiality preserved using codes instead of identifiable variables.
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Study samples
During the period 2002 to 2010, 651 Mtb isolates from Valle del Cauca, Colombia were sent to
CIDEIM from public and private health institutions. Drug susceptibility testing (DST) was
performed by the agar proportion method on Middlebrook 7H10 media for both first (isonia-
zid, rifampicin, ethambutol, and streptomycin) and second line antibiotics (amikacin, cipro-
floxacin or moxifloxacin) [24]. The strains were stored at -80˚C. For further characterization,
we randomly selected 311 isolates: 106 MDR, 39 monoresistant to isoniazid, and 166 drug-sus-
ceptible, to balance the sample set (Fig 1).
Phylogenetic analysis
All 311 isolates were characterized through spoligotyping as described by Kamerbeek et al.,
[25]. The Beijing genotype was detected in 37 strains, being 25 of them already reported in a
previous study [21] and 12 newly identified here. Subsequently, we analyzed the 37 Mtb Beijing
strains by the high-resolution Mycobacteria Interspersed Repetitive Unit–Variable Number
Tandem Repeat (MIRU-VNTR) 24 loci typing [26]. For this purpose, DNA was extracted
using the Cetrimonium bromide-CTAB method [27]. Agarose gel electrophoresis was per-
formed to determine the number of repeats for each locus. Finally, we used Quantity one soft-
ware (Biorad1) to determine the length of the PCR products for each of the 24 loci analyzed
Fig 1. Workflow for the selection of Mycobacterium tuberculosis strains to identify and characterize Beijing strains from
Southwestern Colombia. DST: Drug susceptibility testing; MDR: Multidrug Resistant; MIRU-VNTR: Mycobacteria Interspersed
Repetitive Unit–Variable Number Tandem Repeat; MLPA: Multiplex Ligation-dependent Probe Amplification; LPA: Line probe
assays; WGS: Whole Genome Sequencing.
https://doi.org/10.1371/journal.pone.0224908.g001
PLOS ONE Modern Beijing M. tuberculosis strains from Southwestern Colombia
PLOS ONE | https://doi.org/10.1371/journal.pone.0224908 April 24, 2020 3 / 13
and for allelic assignation. External quality control was assessed through the participation in
the second worldwide proficiency study of MIRU-VNTR [28].
Beijing strains sublineage identification
In order to confirm the genetic background (Beijing sublineage) and the clonality of these
Beijing strains, at least two representative strain of each cluster based on MIRU-VNTR 24 loci
classification was selected as well as the two unique types (n = 10) (Fig 1). These analyses
included the evaluation of RD105, RD207, RD131 and SNPs at codons fbpB-238, mutT2-58,
and the acs1551 nucleotide by the Multiplex Ligation-dependent Probe Amplification (MLPA)
assay with the readout facilitated by the Luminex bead technology, as previously described [6].
The MLPA analysis was conducted by the Royal Tropical Institute (KIT) in The Netherlands.
To classify the Beijing strains into the “modern” or “ancient” sublineages, we followed the
algorithm proposed by Bergval et al., [6].
Detection of mutations associated with drug resistance
DNA was extracted according to the manufacturer´s instructions (HainLifescience GmbH,
Nehren, Germany). Mutations associated with resistance to first line drugs isoniazid (katG and
inhA) and rifampicin (rpoB) were detected using the line probe assay GenoType1MTBDRplus.
Likewise, mutations associated to second line anti-TB drugs fluoroquinolones (gyrA), ethambu-
tol (embB), and aminoglycosides (rrs), were detected using GenoType1MTBDRsl (HainLi-
fescience, Nehren, GmbH, Germany). Mutations were confirmed at KIT, following the SNP
detection protocol described by Sengstake et al., [29].
Whole genome sequencing analysis
Based on the drug susceptibility profile, two out of 37 Beijing strains were selected for whole
genome sequencing (WGS): one drug-susceptible and one MDR strain. The MDR strain
selected for WGS later evolved to XDR. Library preparation and Illumina HiSeq 2000-WGS
were performed as previously described [30]. WGS was performed at the Broad Institute.
Analysis of Sequence Read Archive (SRA) files was done using the CLC genomics workbench
12 software, having the H37Rv NC_000962.3 as the reference Mtb sequence.
Data analysis
The SIT number and the 24 Multi Locus Variable-number-tandem-repeat Analysis (MLVA)
were determined using the http://www.miru-vntrplus.org web page and SITVIT2 (database of
the Pasteur Institute of Guadeloupe) [31]. The information obtained was used to build the
phylogenetic analysis. VNTR typing results were compared to the database at the National
Institute for Public Health and the Environment (RIVM) in the Netherlands.
Results
Samples characteristics
From 2002 to 2010, we identified 37 Beijing strains from Mtb isolates collected in Southwest-
ern Colombia by spoligotyping (Fig 1). Phenotypic DST showed that 30 of these strains were
MDR, six XDR, and only one was drug susceptible to all drugs evaluated. Beijing strains were
found more frequently among female (23/37, 62%) and young patient´s, with a median age of
29 years (IQR: 24–40 years). Most of the Beijing isolates were from pulmonary TB cases (34/
35, 97.1%); 39% (14/36) were new cases exhibiting MDR (n = 12) or XDR (n = 2) phenotype.
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Likewise, most of the Beijing strains were isolated from patients from Buenaventura (86%, 32/
37) (Table 1 and S1 Table).
Phylogenetic classification
All except one Beijing strain were typed as SIT190 (000000000003731), the remaining drug-
susceptible strain was typed as SIT1 (000000000003771). MIRU-VNTR 24 loci analysis dis-
criminated the 37 Beijing strains into three clusters, A to C, and two unique strains (Table 1),
with a clustering rate of 86.5%, calculated with the formula presented by Meehan et al, 2018
[32]. Overall, two loci (QUB11b and MIRU39) exhibited the highest allelic diversity in the
SIT190 Beijing strains (Fig 2). Specifically, MIRU39 revealed the highest differences, with two,
three, and four repeats among the Beijing SIT190 strains. In addition, five more loci (Mtub39,
Mtub04, MIRU31, 27, and 40) showed different number of repeats between SIT190 and SIT1
(Fig 2). The discriminatory power index of MIRU-VNTR 24 loci (D = 0.3799) was superior
Table 1. Characteristics of TB patients and 24-loci MIRU-VNTR Beijing clusters.
Characteristics Total of Beijing strains (n = 37) Beijing classification by MIRU
Cluster A (n = 4) Cluster B (n = 29) Cluster C (n = 2) Unique (38765) Unique (38088)
MLPAa analysis 10 3 3 2 1 1
Sex
Female 23 (62.2%) 2 20 0 0 1
Male 14 (37.8%) 2 9 2 1 0
Origen
Buenaventura 32 (86.5%) 4 24 2 1 1
Other 3 (8.1%) 0 3 0 0 0
NA 2 (5.4%) 0 2 0 0 0
Age (years)
0–16 4 (10.8%) 0 4 0 0 0
17–31 16 (43.2%) 0 15 0 1 0
32–50 11 (29.8%) 2 7 1 0 1
>50 4 (10.8%) 1 2 1 0 0
NA 2 (5.4%) 1 1 0 0 0
Clinical presentation
Pulmonary 34 (91.9%) 4 26 2 1 1
Extrapulmonary 1 (2.7%) 0 1 0 0 0
NA 2 (5.4%) 0 2 0 0 0
Condition
New 15 (40.6%) 3 10 1 0 1
Previously treated 13 (35.1%) 1 11 0 1 0
NA 9 (24.3%) 0 8 1 0 0
Drug susceptibility profile
MDR 32 (86.5%) 4 26b 1 1c 0
XDR 4 (10.8%) 0 3 1 0 0
Drug Susceptible 1 (2.7%) 0 0 0 0 1
NA: Information not available. MIRU-VNTR: Mycobacteria Interspersed Repetitive Unit–Variable Number Tandem Repeat.
a. Number of strains selected for Multiplex Ligation-dependent Probe Amplification (MLPA).
b. Two patients later evolved to XDR-TB.
c. This patient evolved to XDR-TB.
https://doi.org/10.1371/journal.pone.0224908.t001
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compared to the discriminatory power index of spoligotyping (D = 0.0541) as defined by
Hunter and Gaston [33].
Beijing strains sublineage
Based on the phylogenetic analysis derived from MIRU-VNTR 24-loci analysis, we selected
10 representative samples of each cluster, as follows: cluster A = 3, B = 3, C = 2, and the two
unique strains (Figs 1 and 2). The East/Asian RD105 deletion was present in all ten Beijing
strains, confirming their identification as members of the Beijing lineage 2 (or East Asian line-
age). These representative set of samples was further classified as “modern” Beijing sublineage
clade Vietnam (V+)/China (CHIN+) based on intact RD207 and RD131, together with the
SNPs at fbpB238 and mutT2-58 (Table 2) [6, 7].
Mutations associated with drug resistance
A total of 33 (29 MDR and 4 XDR) out of the 37 Beijing strains were successfully evaluated for
the presence of mutations associated with first- and second-line drug resistance (Table 3 and
S1 Table). Three Beijing Mtb strains were excluded from the analysis because they did not
hybridize the amplification control band for either first- or second-line probe assay. Addition-
ally, three strains did not hybridize the amplification control band for GenoType MDRsl only,
while two additional strains did not have a valid result for the rrs gene. The susceptible strain
Fig 2. Unweighted pair group method with arithmetic mean (UPGMA) tree of the Beijing strains discriminated
by spoligotyping and MIRU-VNTR. 24 Multi locus variable-number-tandem-repeat analysis (MLVA) typing refers to
the 15 most discriminatory and 9 ancillary loci defined by Weniger et al., 2010 (31). Interrogation mark represent
genotypes not previously reported or orphan. Clusters A to C defined based on MIRU analysis. MIRU-VNTR:
Mycobacteria Interspersed Repetitive Unit–Variable Number Tandem Repeat.
https://doi.org/10.1371/journal.pone.0224908.g002
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was not tested. The mutations S531L in rpoB and S315T in katG, associated with resistance to
rifampicin and isoniazid, respectively, were the most frequently found in MDR cases (Table 3).
All four XDR strains were confirmed using the genotype analysis that also allowed the
detection of four additional pre-XDR strains (defined as an MDR strain that is also resistant to
either a fluoroquinolone or a second-line injectable) [34]. The SNP M306V in the embB gene
was the most frequently encountered among the ethambutol resistant strains (Table 3).
Whole genome sequencing analysis
Two Beijing strains were analyzed in duplicate by WGS, 38088 (drug susceptible) and 38765
(MDR). The genome data are available at the National Center for Biotechnology Information
(NCBI) under the BioProject identifiers PRJNA227751 and PRJNA227755 respectively. SRA
data SRS565195 and SRS565201 were used for the SNP detection analysis. The average cover-
age was 23X for the MDR Beijing (38765) and 55X for the drug susceptible Beijing (38088).
WGS analysis confirmed the SNPs at mutT2-58 and fbpB-238 genes for the “modern” Bei-
jing sublineage classification (Table 2). We also found a total of 44 and 72 SNPs previously
Table 2. Results of molecular markers for Beijing classification.
Strain number Molecular markers for Beijing classification
RD105 deletion fbpB 238 RD207 deletion mutT2 58 acs 1551(G/A) RD131 deletion Beijing classificationa
35049 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
41921 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
44213 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
47026 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
36366 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
36918 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
50148 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
47197 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
38765 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
38088 Positive CCC to CCAb Negative GGA to CGAc Negative Negative Clade V+, CHIN+
CHIN: China, V: Vietnam.




Table 3. Frequency of mutations associated with drug resistance in “modern” Beijing strains from Southwestern Colombia.
Gene mutation probe (mutation) % of strains (# genotypically resistant /# tested strains by LPA) Drug
rpoB MUT3 (S531L/tcg>ttg) 97 (32/33) Rifampicin
katG MUT1 (S315T/agc>acc) 100 (33/33) Isoniazid
inhA MUT1 (c-15ta) 3 (1/33) Isoniazid/Ethionamide/Prothionamide
gyrA MUT3C (D94G/ gac>ggc) 13 (4/30)b Fluoroquinolones
rrs MUT1 (a1401g) 29 (8/28) Aminoglycosides
embB MUT1B (M306V/atg>gtg) 91 (29/30) Ethambutol
DST: drug susceptibility testing by the agar proportion method. LPA: Line Probe Assay. Lower case indicates the nucleotide changes while uppercase letter indicates
aminoacid change.
a. Mutation in the regulatory region.
b. One strain had double mutations MUT3A (D94A) and MUT3C (D94G).
https://doi.org/10.1371/journal.pone.0224908.t003
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reported in the “modern” and 2.2.1 sublineage Beijing previously reported in Asian countries
(S2 Table). These mutations include the C1477596T SNP (ogt at codon 12).
All SNPs associated with the MDR phenotype were confirmed for the strain 38765. WGS of
the MDR strain also allowed the identification of eight SNPs that had been previously reported
in MDR Beijing strains from Colombia by Rodriguez-Castillo et al., [35] (Table 4). Among
other relevant SNPs, both Beijing strains (38088 and 38765) exhibited an insertion of a Gua-
nine at the position 1406760^1406761 in the Rv1258c gene. There was also an exclusive muta-
tion found in the strain 38088, the synonymous SNP in the cysA3 gene.
Discussion
Modern Beijing sublineage has been associated with emergence and dissemination of drug
resistance TB and higher virulence worldwide (10). Here, we reported the identification of 37
Mtb “modern” Beijing strains isolated from Southwestern Colombia TB cases in a 9-year
period. Most of these “modern” Beijing strains (36/37) were MDR or XDR, strongly suggesting
an association with drug resistance. Interestingly, a large proportion of the drug resistant strains
were isolated from TB patients from Buenaventura (S1 Table and Table 1), confirming previous
findings that suggested Buenaventura as a hotspot for MDR-TB and the Mtb Beijing linage [21,
22]. The highly homogeneous Beijing-MDR cluster SIT190 was further discriminated in three
clusters by MIRU-VNTR 24-loci typing (Fig 2). The homogeneity observed in the “modern”
Beijing strains from Southwestern Colombia, and the fact that most of them were isolated from
new (not-previously treated) TB patients (40.6%, Table 1), suggest active transmission of these
MDR strains.
Beijing strains (mostly, SIT190) isolated in Colombia have shown highly drug-resistant phe-
notypes and this varies from the Beijing strains isolated in other South American countries,
where there is not frequent association with drug resistance thus far [9, 14, 19]. Our findings
support the hypothesis that different Beijing strains were introduced at different occasions in
South American countries, most likely reflecting the diversity in human migration since ancient
times [12]. This is also in agreement with the findings of Schürch, et al., on the introduction of
multiple sources of spread of Beijing strains to different geographical areas on many different
occasions [36]. The “modern” Beijing strains isolated in Colombia are highly conserved and
this may reflect their recent introduction and spreading.







Mutation in other Beijing strains from
Colombia (35)
Mutation in MDR Beijing
strain 38765
Mutation in DS Beijing
strain 38088
Rv0355c PPE8 434226 A Deletion Wild type Wild type
Rv0355c PPE8 434227 C Wild type Deletion Wild type
Rv0197 Rv0197 233949 C T T Wild type
Rv0753c mmsA 845542 G A A Wild type
Rv0988 Rv0988 1106176 A C C Wild type
Rv1723 Rv1723 1950068 C T T Wild type
Rv2308 Rv2308 2580877 G T T T
Rv2940c Rv2940c 3279637 G A A Wild type
Rv3806c ubiA 4269304 A C C Wild type
Rv3862c whiB6 4338365 A G/C G Wild type
DS: Drug susceptible. MDR: Multidrug Resistant
https://doi.org/10.1371/journal.pone.0224908.t004
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Recently, Beijing genotype was found in Mtb strains from two indigenous patients from a
community in the Colombian pacific region. These Beijing strains belonged to SIT190 and
SIT406, one of them being MDR [37]. Additionally, from 2013 to 2015, two Beijing strains
were found in Cali, the most populated city in the Colombian pacific area [38]. Collectively,
these findings suggest the potential spreading of Beijing strains from Buenaventura to other
cities in the Colombian pacific region, with the likelihood to cause MDR-TB cases, and the
need to strengthen surveillance strategies.
We detected a high frequency of young female TB patients infected with Beijing strains.
This distribution was particularly observed in the cluster “B” identified by MIRU-VNTR typ-
ing (Table 1). This finding agrees with previous reports from Malawi, where there were more
women than men infected with Beijing strains, albeit without association with drug resistance
[4, 39]. Of note, the “modern” Beijing sublineage was associated with female young patients
and drug resistance in a recent study from Vietnam [40], as we observed in our study. Addi-
tionally, an important trend between female and MDR-TB in patients from South America
and other geographical areas has been reported [41–44]. The link we found between female
and MDR “modern” Beijing strains is intriguing since Mtb has affected mostly men specially
in low and middle-income countries [45] and there is also evidence of some Beijing strains
affecting more frequently men than women (2:1 ratio approximately) [4, 46, 47].
WGS analyses of two isolates (One SIT190/MDR and one SIT1/drug susceptible) confirmed
the “modern” Beijing sublineage. Although, we only have the data for two out of the 37 Beijing
strains, both strains shared all the 72 and 44 SNPs with the 2.2.1 “modern” sublineage of Bei-
jing (S2 Table) mostly identified from China, Russia and Thailand [10, 48]. These additional
genetic descriptions revealed great similarity of the Beijing strains isolated in Colombia with
“modern” Beijing strains from Asia instead of the Pacific or Asian-African Beijing sublineages
[48]. Additionally, our MDR strain that was sequenced shared the eight SNPs that were pro-
posed to be exclusively present in Beijing MDR strains from Colombia (Table 4) [35]. On the
other hand, the drug-susceptible Beijing strain only shared one mutation with another “Bei-
jing-like” strains from Colombia (Table 3) [38]. This SNP was in the Rv2308 gene that encodes
a conserved hypothetical protein that may act as a transcriptional regulator [49]. Importantly,
the SNP found in Rv2308 has not been identified in other Beijing strains from South Africa or
Asia [36].
A large proportion of our Beijing strains were phenotypically resistant to streptomycin (33/
37 strains) (S1 Table). WGS showed a SNP at Rv1258c that encodes for an efflux pump, proba-
bly linked to streptomycin resistance. This SNP was previously identified in “modern” Beijing
strains from Guatemala [50].
We acknowledge several limitations of the present study. The study design included a conve-
nience sampling with a limited number of Beijing isolates that were available in a repository
from Colombia. Nevertheless, the samples included all Beijing strains found in this setting dur-
ing a 9-years period. Additionally, the repository was built over the years based on cultures sent
to CIDEIM for surveillance purposes. Due to budget constraints, only a few samples were ana-
lyzed by all the methodologies, yet the study strategy achieved the representativeness sought.
Although there is not consensus on which SNPs are most informative and reliable to accurately
describe the phylogeny of Beijing genotype [7], we could successfully classify our Beijing strains
into the “modern” sublineage; following the algorithm proposed by Bergval et al., [6]. Informa-
tion obtained by high throughput technologies, like WGS, will shortly improve our understand-
ing and definition of Beijing strains circulating locally and worldwide, but such technologies
are not readily available in all settings.
In conclusion, Beijing strains that circulated in Colombia from 2002 to 2010 belong to a
genetically conserved cluster of “modern” Beijing strains, and have important phenotypic
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differences with Beijing strains circulating in other South American countries (most of them
being MDR strains). Surveillance and monitoring of the local Mtb population structure are
key strategies to facilitate the development of specific measures to control MDR-TB.
Supporting information
S1 Table. Phenotypic drug susceptibility profile and epidemiological data of the Beijing
TB cases from Colombia.
(XLSX)
S2 Table. SNPs found in Beijing strains from Colombia that were shared with previous
WGS studies of Beijing strains worldwide.
(XLSX)
Acknowledgments
We want to acknowledge local health authorities from Valle del Cauca State and the city of
Santiago de Cali, for facilitating this work. We would also want to thank Juan Carlos Rozo
from CIDEIM, Sarah Sangstake and Indra Bergval from KIT Amsterdam for their technical
support. Additionally, we want to thank Dr. Ashlee Earl, the Broad Institute and to Corpogen
for the whole genome sequencing analysis. We also want to thank Dr. Nancy Gore Saravia, for
her valuable input to this manuscript.
Author Contributions
Conceptualization: Luisa Maria Nieto Ramirez, Beatriz E. Ferro.
Data curation: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Richard M. Anthony, Dick van
Soolingen.
Formal analysis: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Gustavo Diaz, Richard M.
Anthony, Dick van Soolingen.
Funding acquisition: Beatriz E. Ferro, Dick van Soolingen.
Investigation: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Gustavo Diaz, Richard M.
Anthony, Jessica de Beer, Dick van Soolingen.
Methodology: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Gustavo Diaz, Richard M.
Anthony, Dick van Soolingen.
Project administration: Beatriz E. Ferro, Dick van Soolingen.
Resources: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Jessica de Beer.
Software: Luisa Maria Nieto Ramirez, Gustavo Diaz.
Supervision: Beatriz E. Ferro, Richard M. Anthony, Dick van Soolingen.
Validation: Beatriz E. Ferro, Richard M. Anthony, Jessica de Beer, Dick van Soolingen.
Visualization: Luisa Maria Nieto Ramirez, Gustavo Diaz, Jessica de Beer, Dick van Soolingen.
Writing – original draft: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Gustavo Diaz.
Writing – review & editing: Luisa Maria Nieto Ramirez, Beatriz E. Ferro, Gustavo Diaz, Rich-
ard M. Anthony, Jessica de Beer, Dick van Soolingen.
PLOS ONE Modern Beijing M. tuberculosis strains from Southwestern Colombia
PLOS ONE | https://doi.org/10.1371/journal.pone.0224908 April 24, 2020 10 / 13
References
1. World Health Organization. Global Tuberculosis Report. 2019.
2. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains
of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002; 8(8):843–9. https://doi.
org/10.3201/eid0808.020002 PMID: 12141971
3. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence
of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010; 10(2):103–11.
https://doi.org/10.1016/S1473-3099(09)70330-5 PMID: 20113979
4. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology
and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance.
Emerg Infect Dis. 2006; 12(5):736–43. https://doi.org/10.3201/eid1205.050400 PMID: 16704829
5. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuber-
culosis W-Beijing family strains. Trends Microbiol. 2002; 10(1):45–52. https://doi.org/10.1016/s0966-
842x(01)02277-6 PMID: 11755085
6. Bergval I, Sengstake S, Brankova N, Levterova V, Abadı́a E, Tadumaze N, et al. Combined species
identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis cultures by
MLPA on a bead-based array. PLoS One. 2012; 7(8):e43240. https://doi.org/10.1371/journal.pone.
0043240 PMID: 22916230
7. Shitikov E, Kolchenko S, Mokrousov I, Bespyatykh J, Ischenko D, Ilina E, et al. Evolutionary pathway
analysis and unified classification of East Asian lineage of Mycobacterium tuberculosis. Sci Rep. 2017;
7(1):9227. https://doi.org/10.1038/s41598-017-10018-5 PMID: 28835627
8. Mokrousov I, Ly HM, Otten T, Lan NN, Vyshnevskyi B, Hoffner S, et al. Origin and primary dispersal of
the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res.
2005; 15(10):1357–64. https://doi.org/10.1101/gr.3840605 PMID: 16169923
9. Iwamoto T, Grandjean L, Arikawa K, Nakanishi N, Caviedes L, Coronel J, et al. Genetic diversity and
transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru. PLoS One.
2012; 7(11):e49651. https://doi.org/10.1371/journal.pone.0049651 PMID: 23185395
10. Liu Q, Luo T, Dong X, Sun G, Liu Z, Gan M, et al. Genetic features of Mycobacterium tuberculosis mod-
ern Beijing sublineage. Emerg Microbes Infect. 2016; 5:e14. https://doi.org/10.1038/emi.2016.14
PMID: 26905026
11. de Keijzer J, de Haas PE, de Ru AH, van Veelen PA, van Soolingen D. Disclosure of selective advan-
tages in the "modern" sublineage of the Mycobacterium tuberculosis Beijing genotype family by quanti-
tative proteomics. Mol Cell Proteomics. 2014; 13(10):2632–45. https://doi.org/10.1074/mcp.M114.
038380 PMID: 25022876
12. Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, et al. Out-of-Africa migration and Neo-
lithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013; 45(10):1176–
82. https://doi.org/10.1038/ng.2744 PMID: 23995134
13. Ribeiro SC, Gomes LL, Amaral EP, Andrade MR, Almeida FM, Rezende AL, et al. Mycobacterium
tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased
virulence than strains of the ancient sublineage. J Clin Microbiol. 2014; 52(7):2615–24. https://doi.org/
10.1128/JCM.00498-14 PMID: 24829250
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49. Camus JC, Pryor MJ, Médigue C, Cole ST. Re-annotation of the genome sequence of Mycobacterium
tuberculosis H37Rv. Microbiology. 2002; 148(Pt 10):2967–73. https://doi.org/10.1099/00221287-148-
10-2967 PMID: 12368430
50. Saelens JW, Lau-Bonilla D, Moller A, Medina N, Guzmán B, Calderón M, et al. Whole genome sequenc-
ing identifies circulating Beijing-lineage Mycobacterium tuberculosis strains in Guatemala and an asso-
ciated urban outbreak. Tuberculosis (Edinb). 2015; 95(6):810–6.
PLOS ONE Modern Beijing M. tuberculosis strains from Southwestern Colombia
PLOS ONE | https://doi.org/10.1371/journal.pone.0224908 April 24, 2020 13 / 13
